Approval · Notice of Compliance 35673 · 2025
SAIZEN: Notice of Compliance 35673
Issued July 11, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35673
- Date
- July 11, 2025
- Company
- Emd Serono A Division Of Emd Inc CanadaMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Replacement of reference standard
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SAIZEN | Not yet assigned | — |
Medicinal ingredients
- SOMATROPIN 5.83 MG per CART
- SOMATROPIN 8 MG per CART
- SOMATROPIN 20 MG per CART
- SOMATROPIN 5 MG per VIAL